Home
Organisers & Sponsors
Program
Speaker Profiles
Social Events
Abstracts
Awards & Grants
Venue & Hotel Reservations
Accommodation
Registration & Forms
Contact
 

 

 

 

 

 

 

 

 

SUNDAY 9
SEPTEMBER

 

 

 

 

Council Meeting

Registration

14:00

 

Council Meeting

16:00-17:00

 

Servier Symposium

18:00

 

Welcome Cocktail Party

Queenstown Room

 

 

 

MONDAY 10 SEPTEMBER

 

 

07:00

 

Inigo Room – Meet the Professor 1.
Best practice for mouse skeletal analysis.

Natalie Sims

Limited to 30 people. Booking essential.
Cost: A$30, book a seat when you register.
Includes: breakfast and discussion.

07:00

 

Clancy’s Room – Meet the Professor 2.
Management and diagnosis of osteoporosis

Peter Ebeling

Limited to 30 people. Booking essential.
Cost: A$30, book a seat when you register.
Includes: breakfast and discussion.

 

 

 

08:30

 

Opening and welcome
Coronet Room

Jill Cornish

 

 

G-protein coupled receptors in bone

Chairs: Rachel Davey, David Findlay

08:35

IS1

Catabolic and anabolic actions of PTH

Jack Martin

09:00

IS2

Calcitonin receptor function

Jeff Zajac

09:25

IS3

RAMPs modulating Calcitonin receptor function

Dorit Naot

09:50

OR1

The Calcitonin Receptor Plays A Physiological Role In Maintaining Trabecular Bone Volume In Young Female And Adult Male Mice

Maria Chiu

 

 

 

10:02

 

Refreshments – 5th Floor

 

 

 

10:30

 

Absolute Risks – Coronet Room

Chairs: Emma Duncan, John Wark

10:30

IS4

Risk of fracture and treatment of osteoporosis

Steven Cummings

11:10

IS5

Toward the individualisation of fracture risk

Tuan Nguyen

11:36

OR2

Can bone density assessed by DXA at age 8 predict fracture risk in males and females during puberty?

Jenny Flynn

11:48

OR3

Endogenous sex hormones and incident fracture risk in older men: The Dubbo osteoporosis epidemiology study (DOES)

Markus Seibel

12:00

 

Lunch – 5th Floor

 

 

 

13:00

 

Calcium – Coronet Room

Chairs: Rory Clifton-Bligh, Kathy Briffa

13:00

IS6

Why should we think about calcium?
 

Chris Nordin

13:28

IS7

Calcium and Vitamin D for whom, when and why
 

Richard Prince

13:56

IS8

Bone and non-bone effects of calcium

Ian Reid

14:24

OR4

Bone turnover is higher and bone density lower in adolescents with subclinical vitamin D deficiency

Tania Winzenberg

14:36

OR5

Low vitamin D status increases osteoclastogenesis and bone loss in the rat

Peter O’Loughlin

14:48

OR6

Accelerated bone resorption, due to dietary calcium deficiency, promotes tumour growth in a murine model of breast cancer bone metastasis

Colin Dunstan

 

 

 

15:00

 

Refreshments – 5th Floor

15:30

 

Posters – Clancy’s Room & 5th Floor

17:30-18:30

 

Sanofi-Aventis Symposium tbc

 

 

Student’s BBQ – Peppers Hotel

19:30

 

President’s Dinner

 

 

 

TUESDAY 11 SEPTEMBER

 

 

07:00

 

Inigo Room – Women’s Breakfast
An event to help establish mentoring and networking opportunities for women in the ANZBMS with respect to career advancement, academic promotion and combining careers with family.

Hosted by Nicky Partridge

Limited to 30 people. Booking essential.
Cost: A$30, book a seat when you register.
Includes: breakfast and discussion

 

 

Clancy’s Room – Meet the Professor 3.
RANKL – lessons from the lab, mice and man

Colin Dunstan

Limited to 30 people. Booking essential.
Cost: A$30, book a seat when you register.
Includes: breakfast and discussion

 

 

 

08:30

 

Arthritis and Gout – Coronet Room

Chairs: Nicole Walsh, Nick Fazzalari

08:30

IS9

Mechanism of bone erosion in chronic tophaceous gout

Nicola Dalbeth

08:55

IS10

The role of bone in osteoarthritis

Graeme Jones

09:20

IS11

Insights on arthritis from animal models

Chris Little

09:48

OR7

Osteoclastogenesis Inhibitors Modulate Experimental Osteoarthritis

Evange Romas

 

 

 

10:00

 

Refreshments – 5th Floor

 

 

 

10:30

 

Clinical Presentations – Coronet Rooms

Chairs: Ailsa Goulding, Peter Nash

10:30

OR8

Sexual dimorphism in radial and longitudinal bone growth differ by tempo and magnitude: a study in male-female co-twins pairs

Sandra Iuliano-Burns

10:42

OR9

Bone mass tracks strongly from childhood to adolescence

Stella Foley

10:54

OR10

Clinical nomogram for individualizing 5-year and 10-year risk of fracture

Nguyen Nguyen

11:06

OR11

Bone varies its spatial distribution rather than its mass to optimise strength and minimize bulk

Roger Zebaze

11:18

OR12

Hypovitaminosis D and parathyroid hormone response in the elderly: effects on bone turnover and mortality

Philip Sambrook

11:30

OR13

The effect of a one-year randomised resistance exercise and walking intervention on the prevention of bone loss in older men

Joanna Whiteford

11:42

OR14

Depression and falls: Geelong osteoporosis study

Lana Williams

11:56

OR15

Hypercalcaemia and undetectable serum PTH: a case of primary hyperparathyroidism due to secretion of a mutant PTH

Rory Clifton-Bligh

12:08

OR16

A phase 1 genomewide association study in osteoporosis

Emma Duncan

12:20

OR17

RANKL/RANK/OPG in breast cancer metastasis to bone

Katherine Mackie

 

 

 

10:30

 

Basic Presentations – Remarkables Rooms

Chairs: Nicky Partridge, Colin Dunstan

10:30

OR18

Imatinib mesylate inhibits bone formation and decreases bone mass in vivo by inhibiting PDGFR-mediated osteoblast mitogenesis.

Andrew Grey

10:42

OR19

Androgens act directly via the androgen receptor in mineralising osteoblasts to maintain trabecular bone in male mice by regulating bone turnover

Rachel Davey

10:54

OR20

Oncostatin m is an essential stimulus of bone formation and osteoclastogenesis

Natalie Sims

11:06

OR21

Neuropeptide Y protects the skeleton from bone loss induced by stress

Paul Baldock

11:18

OR22

Osteoclast formtation and osteolysis are promoted by the amp-activated protein kinase (AMPK) activator aminoimidazole-4-carboxamide ribonucleoside (AICAR) in vivo

Julian Quinn

11:30

OR23

Adiponectin knock-out mice have increased trabecular number and bone volume at 14 weeks of age

Garry Williams

11:42

OR24

Adverse effects of valproate on bone: defining a model to investigate the pathophysiology

Susan Kantor

11:56

OR25

RUNX2 Trinucleotide repeat mutations are associated with decreased bone density and altered protein function

Alexandre Stephens

12:08

OR26

TWEAK inhibits human osteoblast differentiation and modulates the activity of TNF-a on osteoblast behaviour, in part through mitogen activated kinase (MAPK) induction of Sclerostin expression

Tina Vincent

12:20

OR27

Potential role of Rab3D-calmodulin interaction in osteoclastic bone resorption

Jiake Xu

 

 

 

12:32

 

Lunch – 5th Floor

 

 

 

12:32-13:30

 

MERCK Symposium tbc

 

 

 

 

 

Cell attachment – Coronet Room

Chairs: Gethin Thomas, Rebecca Mason

13:30

IS12

Role of alpha v beta 3 integrin in osteoclast function: From attachment assays to clinical trials
 

Sevgi Rodan

14.10

IS13

The effect of surface chemistry modification of implants


Hala Zreiqat

14:36

OR28

Most outstanding clinical abstract, Prediction of vertebral body bone strength: the contribution of individual trabecular elements
 

Ian Parkinson

14:48

OR29

Most outstanding basic abstract, Osteoblast-targeted disruption of glucocorticoid signalling delays intramembranous bone development in vivo
 

Hong Zhou

 

 

 

15:00

 

Refreshments – 5th Floor

 

 

 

Effects of Treatment

Chairs: Kerrie Sanders, Chris Nordin

15:30

IS14

Telling the effects of treatment: trials and observational studies

Steven Cummings

16:00

IS15

Falls prevention-risk factors and RCTs

Bob Cummings

16:24

IS16

Effectiveness of fracture prevention

Kerrie Sanders

16:48

OR30

A RCT of the effects of vitamin D and calcium on bone structure and muscle strength in older women with vitamin D insufficiency

Richard Prince

 

 

 

17:00

 

ANZBMS AGM

 

19:30

 

Conference Dinner

Benlomond Resteaurant – 6th Floor

 

 

 

WED 12 SEPTEMBER

 

 

07:00

 

Fun Run / Walk - Lake Wakatipu Pathway (opposite Rydges)

 

 

 

 

 

New Targets – Coronet Room

Chairs: Nicola Dalbeth, Mark Kotowicz

09:00

IS17

Cathepsin K, a new molecular target for treatment of osteoporosis

Sevgi Rodan

09:24

IS18

Protease-activated receptors and thrombin

Eleanor Mackie

09:48

OR31

Osteal macrophages: novel regulators of bone formation

Liza Raggatt

 

 

 

10:00

 

Refreshments – 5th Floor

 

 

 

10:30

 

New Targets (cont.) – Coronet Room

10:30

IS19

PPAR gamma – an osteoblast and adipocyte switch

Geoff Nicholson

10:55

IS20

The skeletal consequences of thiazolidinediones in humans

Andrew Grey

 

 

 

11:20

 

Cellular Commitment and communication – Coronet Room

Chairs: Edith Gardiner, Nathan Pavlos

11:20

IS21

Bone marrow stromal stem cells

Stan Gronthos.

11:45

IS22

Chemokines and Cytokines Involved in PTH's Actions

Nicky Partridge

12:10

IS23

Osteocytes and bone health

David Findlay

12: 35

IS24

Osteoclast – Osteoblast Communication

Julian Quinn

 

 

 

13:00

 

Box Lunch – 5th Floor

 

 

 

14:0

 

Close of Meeting

 

 

 

 

 

Copyright Australian and New Zealand Bone
and Mineral Society